NOVO NORDISK SAĞLIK ÜRÜNLERİ TİCARET LİMİTED ŞİRKETİ

NOVO NORDISK SAĞLIK ÜRÜNLERİ TİCARET LİMİTED ŞİRKETİ is a trading company.

Company Introduction:

NOVO NORDISK SAĞLIK ÜRÜNLERİ TİCARET LİMİTED ŞİRKETİ is the Turkish subsidiary of Novo Nordisk A/S, a global healthcare company headquartered in Denmark. This entity primarily functions as the marketing, sales, and distribution arm for Novo Nordisk's pharmaceutical products within Turkey.

The company is responsible for commercializing a range of innovative medicines in key therapeutic areas, most notably diabetes, obesity, and rare blood and endocrine disorders. Its mission is to make these life-saving and life-improving treatments accessible to patients and healthcare professionals throughout Turkey.

As a "Ticaret Limited Şirketi" (Trade Limited Company), its operations focus on the import, promotion, and distribution of products manufactured by its parent company globally, rather than engaging in local manufacturing processes. It plays a crucial role in the Turkish healthcare landscape by ensuring the availability of Novo Nordisk's specialized medications in compliance with local regulations.

Novo Nordisk Sağlık Ürünleri Ticaret Limited Şirketi in Turkey produces or sells products primarily focused on diabetes care, including:

* Insulin (various types such as rapid-acting, long-acting, and premixed)

* GLP-1 receptor agonists (e.g., semaglutide)

* Oral antidiabetic medications

* Needles and injection devices for insulin delivery

* Other diabetes-related products and services.